Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Timed response to inhaled nitric oxide in pulmonary hypertension.

Literature DB >> 25006425

Timed response to inhaled nitric oxide in pulmonary hypertension.

James M Hunt¹, Michael G Risbano², John C Messenger³, John Carroll³, David Badesch¹, Brian D Lowes³, Ivan P Casserly⁴, Joseph Kay³, Todd M Bull¹.

Abstract

Entities: Chemical Disease

Year: 2014 PMID： 25006425 PMCID： PMC4070755 DOI： 10.1086/674880

Source DB: PubMed Journal: Pulm Circ ISSN： 2045-8932 Impact factor: 3.017

× No keyword cloud information.

20 in total

Review 1. Diagnosis of pulmonary arterial hypertension.

Authors: Terence K Trow; John R McArdle
Journal: Clin Chest Med Date: 2007-03 Impact factor: 2.878

2. A USA-based registry for pulmonary arterial hypertension: 1982-2006.

Authors: T Thenappan; S J Shah; S Rich; M Gomberg-Maitland
Journal: Eur Respir J Date: 2007-09-05 Impact factor: 16.671

3. Statistical methods for assessing agreement between two methods of clinical measurement.

Authors: J M Bland; D G Altman
Journal: Lancet Date: 1986-02-08 Impact factor: 79.321

Review 4. Primary pulmonary hypertension.

Authors: L J Rubin
Journal: Chest Date: 1993-07 Impact factor: 9.410

5. Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL).

Authors: Raymond L Benza; Dave P Miller; Mardi Gomberg-Maitland; Robert P Frantz; Aimee J Foreman; Christopher S Coffey; Adaani Frost; Robyn J Barst; David B Badesch; C Gregory Elliott; Theodore G Liou; Michael D McGoon
Journal: Circulation Date: 2010-06-28 Impact factor: 29.690

6. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension.

Authors: S Rich; E Kaufmann; P S Levy
Journal: N Engl J Med Date: 1992-07-09 Impact factor: 91.245

7. Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension.

Authors: O Sitbon; M Humbert; J L Jagot; O Taravella; M Fartoukh; F Parent; P Herve; G Simonneau
Journal: Eur Respir J Date: 1998-08 Impact factor: 16.671

8. Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines.

Authors: Michael McGoon; David Gutterman; Virginia Steen; Robin Barst; Douglas C McCrory; Terry A Fortin; James E Loyd
Journal: Chest Date: 2004-07 Impact factor: 9.410